Effects of prescribed aerobic exercise volume on physical activity and sedentary time in postmenopausal women: a randomized controlled trial.

Jessica McNeil, Megan S Farris, Yibing Ruan, Heather Merry, Brigid M Lynch, Charles E Matthews, Kerry S Courneya, Christine M Friedenreich

Journal: The international journal of behavioral nutrition and physical activity 2018;15(1):27

PMID: 29562927

Plain Language Summary

plain language summary logo

Physical activity has emerged as an important lifestyle factor for primary prevention of numerous diseases, including postmenopausal breast cancer. The aim of this two-armed randomised controlled study was to examine the effects of a year-long prescribed aerobic exercise programme on physical activity levels and sedentary time in postmenopausal women. A total of 400 postmenopausal women aged between 50 – 74 years were randomised to one of the two groups; moderate (150min of exercise/week) or high (300min of exercise/week) volumes of aerobic exercise interventions. Results showed increased activity time in total and moderate-vigorous intensity/recreational physical activity, coupled with decreased sedentary time, in response to both volumes of prescribed physical activity. However, results also showed that physical activity and sedentary time returned to baseline following study completion. Authors conclude that total physical activity time can be increased with greater volumes of prescribed exercise. Furthermore, additional support and resources may be beneficial to promote the maintenance of increased physical activity and reduced sedentary time in the long-term.

Abstract

BACKGROUND

Physical activity has emerged as an important lifestyle factor for primary prevention of numerous diseases, including postmenopausal breast cancer. No study to date has assessed the acute and long-term effects of year-long aerobic exercise programs differing in prescribed exercise volume on physical activity and sedentary time in postmenopausal women. Therefore, we aimed to examine the effects of two moderate-vigorous intensity exercise doses on total, light and moderate-vigorous intensity physical activity times, and sedentary time in postmenopausal women during the year-long intervention and one year later.

METHODS

The Breast Cancer and Exercise Trial in Alberta (BETA) was a two-center, two-arm, 12-month randomized controlled trial that included 400 previously inactive postmenopausal women randomized to either 150 (MODERATE) or 300 (HIGH) minutes/week of aerobic exercise. Physical activity and sedentary time were assessed at baseline, 6- (intervention mid-point), 12- (prior to end of intervention) and 24-months (follow-up) with waist-mounted accelerometers (Actigraph GTX3®). Self-reported activity and sedentary time at baseline, 12- and 24-months was also assessed (Past Year Total Physical Activity Questionnaire and SIT-Q). Intention-to-treat analyses were conducted using linear mixed models and adjusted for baseline variables.

RESULTS

Both physical activity interventions led to increases in objective and subjective measures of total and moderate-vigorous intensity/recreational physical activity time, coupled with decreases in sedentary time, at 6- and 12-months compared to baseline. Additionally, greater increases in accelerometry-derived total physical activity time at 6- and 12-months, and self-reported recreational activity time at 12-months, compared to baseline were noted in the HIGH versus MODERATE groups. Decreases in total, light and moderate-vigorous intensity physical activity time, and an increase in sedentary time, in both groups were noted at 24-months compared to 12-months. A decrease in light intensity physical activity time in both groups at 24-months compared to baseline was also noted.

CONCLUSION

These findings have important health implications, suggesting that total physical activity time can be increased with greater volumes of prescribed exercise, but that additional support and resources could be used to promote the maintenance of these high levels of aerobic exercise participation following study completion.

TRIAL REGISTRATION

clinicaltrials.gov identifier: NCT01435005 (BETA Trial). Registred September 15th 2011 (retrospectively registered).

Address: Department of Cancer Epidemiology and Prevention Research, CancerControl Alberta, Alberta Health Services, Holy Cross Center, Room 514, Box ACB, 2210 2nd Street SW, Calgary, Alberta, T2S 3C3, Canada.; Cancer Epidemiology and Intelligence Division, Cancer Council Victoria, Melbourne, VIC, Australia.; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, VIC, Australia.; Metabolic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.; Faculty of Physical Education and Recreation, University of Alberta, Edmonton, AB, Canada.; Department of Cancer Epidemiology and Prevention Research, CancerControl Alberta, Alberta Health Services, Holy Cross Center, Room 514, Box ACB, 2210 2nd Street SW, Calgary, Alberta, T2S 3C3, Canada. [email protected].; Departments of Oncology and Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada. [email protected].

Patient Centred Factor

Modifiable Lifestyle Factors

Jadad Score

Allocation Concealment

Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.